Abstract
Endometrial cancer is the sixth most common cancer in women worldwide and the most common gynecologic malignancy in the developed world. This chapter explores the current epidemiologic evidence on the association between obesity and endometrial cancer risk and mortality. Using body mass index (BMI) as a measure of obesity, we found that obesity (defined as BMI > 30 and < 35 kg/m2) was associated with a 2.6-fold increase in endometrial cancer risk, while severe obesity (BMI > 35 kg/m2) was associated with a 4.7-fold increase compared to normal-weight women (BMI < 25 kg/m2). Increased central adiposity also increased endometrial cancer risk by 1.5- to twofold. Among both healthy and endometrial cancer patient populations, obesity was associated with a roughly twofold increase in endometrial cancer-specific mortality. This risk reduction was also observed for obesity and all-cause mortality among endometrial cancer patients. In the few studies that assessed risk associated with weight change, an increased endometrial cancer risk with weight gain and weight cycling was observed, whereas some evidence for a protective effect of weight loss was found. Furthermore, early-life obesity was associated with a moderately increased risk of endometrial cancer later in life. There are several mechanisms whereby obesity is hypothesized to increase endometrial cancer risk, including increased endogenous sex steroid hormones, insulin resistance, chronic inflammation and adipokines. Further research should focus on histological subtypes or molecular phenotypes of endometrial tumors and population subgroups that could be at an increased risk of obesity-associated endometrial cancer. Additionally, studies on weight gain, loss or cycling and weight loss interventions can provide mechanistic insight into the obesity–endometrial cancer association. Sufficient evidence exists to recommend avoiding obesity to reduce endometrial cancer risk.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon, France
U.S. Cancer Statistics Working Group (2015) United States Cancer Statistics: 1999–2012 incidence and mortality web-based report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta, GA
Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17
Hecht JL, Mutter GL (2006) Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 24(29):4783–4791. doi:10.1200/jco.2006.06.7173
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491–505. doi:10.1016/s0140-6736(05)67063-8
Mendivil A, Schuler KM, Gehrig PA (2009) Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control 16(1):46–52
Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55(2):74–108
Evans T, Sany O, Pearmain P, Ganesan R, Blann A, Sundar S (2011) Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer 104(9):1505–1510. doi:10.1038/bjc.2011.68
Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR (2011) Trends in endometrial cancer incidence rates in the United States, 1999–2006. J Womens Health (Larchmt) 20(8):1157–1163. doi:10.1089/jwh.2010.2529
Bray F, dos Santos Silva I, Moller H, Weiderpass E (2005) Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomark Prev 14(5):1132–1142. doi:10.1158/1055-9965.epi-04-0871
Fader AN, Arriba LN, Frasure HE, von Gruenigen VE (2009) Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 114(1):121–127. doi:10.1016/j.ygyno.2009.03.039
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2015) SEER cancer statistics review, 1975–2012. National Cancer Institute, Bethesda, MD
Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS, Chan JK (2006) Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 94(5):642–646. doi:10.1038/sj.bjc.6603012
Yap OW, Matthews RP (2006) Racial and ethnic disparities in cancers of the uterine corpus. J Natl Med Assoc 98(12):1930–1933
Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB (2004) Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health 94(12):2104–2111
Sherman ME, Devesa SS (2003) Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98(1):176–186. doi:10.1002/cncr.11484
Schouten LJ, Goldbohm RA, van den Brandt PA (2004) Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 96(21):1635–1638. doi:10.1093/jnci/djh291
Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM (2007) Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 17(2):441–446. doi:10.1111/j.1525-1438.2007.00790.x
Folsom AR, Anderson KE, Sweeney C, Jacobs DR Jr (2004) Diabetes as a risk factor for death following endometrial cancer. Gynecol Oncol 94(3):740–745. doi:10.1016/j.ygyno.2004.06.027
Lindemann K, Cvancarova M, Eskild A (2015) Body mass index, diabetes and survival after diagnosis of endometrial cancer: a report from the HUNT-survey. Gynecol Oncol 139(3):476–480. doi:10.1016/j.ygyno.2015.09.088
Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK (2014) Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol 37(2):131–134. doi:10.1097/COC.0b013e318277d5f4
World Cancer Research Fund/American Institute for Cancer Research (2013) Continuous update project report. Food, Nutrition, Physical Activity, and the Prevention of Endometrial Cancer. http://www.dietandcancerreport.org. Accessed 26/02/2016
Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, Ferlay J, Miranda JJ, Romieu I, Dikshit R, Forman D, Soerjomataram I (2015) Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 16(1):36–46. doi:10.1016/s1470-2045(14)71123-4
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV Jr, Kolonel LN, Henderson BE, Hankinson SE, Hakansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31(20):2607–2618. doi:10.1200/jco.2012.48.2596
Akbayir O, Corbacioglu Esmer A, Numanoglu C, Cilesiz Goksedef BP, Akca A, Bakir LV, Kuru O (2012) Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer. Arch Gynecol Obstet 286(5):1269–1276. doi:10.1007/s00404-012-2431-2
Gates EJ, Hirschfield L, Matthews RP, Yap OW (2006) Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium. J Natl Med Assoc 98(11):1814–1822
Han X, Stevens J, Truesdale KP, Bradshaw PT, Kucharska-Newton A, Prizment AE, Platz EA, Joshu CE (2014) Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality. Int J Cancer 135(12):2900–2909. doi:10.1002/ijc.28930
Bjorge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A (2010) Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 171(8):892–902. doi:10.1093/aje/kwq006
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335(7630):1134. doi:10.1136/bmj.39367.495995.AE
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638. doi:10.1056/NEJMoa021423
Arem H, Chlebowski R, Stefanick ML, Anderson G, Wactawski-Wende J, Sims S, Gunter MJ, Irwin ML (2013) Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women’s Health Initiative. Gynecol Oncol 128(2):181–186. doi:10.1016/j.ygyno.2012.10.029
Arem H, Park Y, Pelser C, Ballard-Barbash R, Irwin ML, Hollenbeck A, Gierach GL, Brinton LA, Pfeiffer RM, Matthews CE (2013) Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst 105(5):342–349. doi:10.1093/jnci/djs530
DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28(2):105–114. doi:10.1016/j.cct.2006.04.004
La Vecchia C, Franceschi S, Decarli A, Gallus G, Tognoni G (1984) Risk factors for endometrial cancer at different ages. J Natl Cancer Inst 73(3):667–671
Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR (1996) Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 88(16):1127–1135
Shoff SM, Newcomb PA (1998) Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 148(3):234–240
Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Rios P, Salmeron-Castro J, Larrea F, Hernandez-Avila M (2000) Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 11(8):707–711
Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA (2000) Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11(2):185–192
Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, Mantzoros CS, La Vecchia C (2004) Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89(3):1160–1163. doi:10.1210/jc.2003-031716
Xu WH, Matthews CE, Xiang YB, Zheng W, Ruan ZX, Cheng JR, Gao YT, Shu XO (2005) Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol 161(10):939–947. doi:10.1093/aje/kwi127
Okamura C, Tsubono Y, Ito K, Niikura H, Takano T, Nagase S, Yoshinaga K, Terada Y, Murakami T, Sato S, Aoki D, Jobo T, Okamura K, Yaegashi N (2006) Lactation and risk of endometrial cancer in Japan: a case-control study. Tohoku J Exp Med 208(2):109–115
Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA (2006) Weight change and risk of endometrial cancer. Int J Epidemiol 35(1):151–158. doi:10.1093/ije/dyi226
Xu WH, Xiang YB, Zheng W, Zhang X, Ruan ZX, Cheng JR, Gao YT, Shu XO (2006) Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol 35(1):159–166. doi:10.1093/ije/dyi223
Machova L, Cizek L, Horakova D, Koutna J, Lorenc J, Janoutova G, Janout V (2007) Association between obesity and cancer incidence in the population of the District Sumperk, Czech Republic. Onkologie 30(11):538–542. doi:10.1159/0000108284
Wen W, Cai Q, Xiang YB, Xu WH, Ruan ZX, Cheng J, Zheng W, Shu XO (2008) The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk. Cancer 112(11):2409–2416. doi:10.1002/cncr.23453
Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, Wilcox H, Soslow R, Zauber AG, Olson SH (2009) Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 20(7):1117–1127. doi:10.1007/s10552-009-9336-9
Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick K, Faulkner S, Zauber AG, Olson SH (2009) Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomark Prev 18(5):1448–1456. doi:10.1158/1055-9965.epi-08-0936
Thomas CC, Wingo PA, Dolan MS, Lee NC, Richardson LC (2009) Endometrial cancer risk among younger, overweight women. Obstet Gynecol 114(1):22–27. doi:10.1097/AOG.0b013e3181ab6784
Tong SY, Ha SY, Ki KD, Lee JM, Lee SK, Lee KB, Kim MK, Cho CH, Kwon SY (2009) The effects of obesity and HER-2 polymorphisms as risk factors for endometrial cancer in Korean women. BJOG 116(8):1046–1052. doi:10.1111/j.1471-0528.2009.02186.x
Charneco E, Ortiz AP, Venegas-Rios HL, Romaguera J, Umpierre S (2010) Clinic-based case-control study of the association between body mass index and endometrial cancer in Puerto Rican women. P R Health Sci J 29(3):272–278
Jeong NH, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, Seo SS, Park CY, Kim KT, Lee J (2010) Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol 118(1):24–28. doi:10.1016/j.ygyno.2010.03.001
John EM, Koo J, Horn-Ross PL (2010) Lifetime physical activity and risk of endometrial cancer. Cancer Epidemiol Biomark Prev 19(5):1276–1283. doi:10.1158/1055-9965.epi-09-1316
Zhang Y, Liu Z, Yu X, Zhang X, Lu S, Chen X, Lu B (2010) The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 117(1):41–46. doi:10.1016/j.ygyno.2009.12.029
Dal Maso L, Tavani A, Zucchetto A, Montella M, Ferraroni M, Negri E, Polesel J, Decarli A, Talamini R, La Vecchia C, Franceschi S (2011) Anthropometric measures at different ages and endometrial cancer risk. Br J Cancer 104(7):1207–1213. doi:10.1038/bjc.2011.63
Hosono S, Matsuo K, Hirose K, Ito H, Suzuki T, Kawase T, Watanabe M, Nakanishi T, Tajima K, Tanaka H (2011) Weight gain during adulthood and body weight at age 20 are associated with the risk of endometrial cancer in Japanese women. J Epidemiol 21(6):466–473
Lu L, Risch H, Irwin ML, Mayne ST, Cartmel B, Schwartz P, Rutherford T, Yu H (2011) Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer 129(5):1237–1243. doi:10.1002/ijc.26046
Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, Negri E, Franceschi S, La Vecchia C (2011) Metabolic syndrome and endometrial cancer risk. Ann Oncol 22(4):884–889. doi:10.1093/annonc/mdq464
Dallal CM, Brinton LA, Bauer DC, Buist DS, Cauley JA, Hue TF, Lacroix A, Tice JA, Chia VM, Falk R, Pfeiffer R, Pollak M, Veenstra TD, Xu X, Lacey JV Jr (2013) Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort. Endocr Relat Cancer 20(1):151–160. doi:10.1530/erc-12-0229
Nagle CM, Marquart L, Bain CJ, O’Brien S, Lahmann PH, Quinn M, Oehler MK, Obermair A, Spurdle AB, Webb PM (2013) Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer. Eur J Cancer 49(12):2717–2726. doi:10.1016/j.ejca.2013.03.015
Olson JE, Sellers TA, Anderson KE, Folsom AR (1999) Does a family history of cancer increase the risk for postmenopausal endometrial carcinoma? A prospective cohort study and a nested case-control family study of older women. Cancer 85(11):2444–2449
Furberg AS, Thune I (2003) Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 104(6):669–676. doi:10.1002/ijc.10974
Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, Feychting M (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106(4):594–599. doi:10.1002/ijc.11266
Lacey JV Jr, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C (2005) Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomark Prev 14(7):1724–1731. doi:10.1158/1055-9965.epi-05-0111
Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2005) Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93(9):1062–1067. doi:10.1038/sj.bjc.6602819
Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P (2006) Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 118(2):458–466. doi:10.1002/ijc.21354
Bjorge T, Engeland A, Tretli S, Weiderpass E (2007) Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120(2):378–383. doi:10.1002/ijc.22260
Chang SC, Lacey JV Jr, Brinton LA, Hartge P, Adams K, Mouw T, Carroll L, Hollenbeck A, Schatzkin A, Leitzmann MF (2007) Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomark Prev 16(4):723–730. doi:10.1158/1055-9965.epi-06-0675
Friedenreich C, Cust A, Lahmann PH, Steindorf K, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S, Linseisen J, Rohrmann S, Boeing H, Pischon T, Tjonneland A, Halkjaer J, Overvad K, Mendez M, Redondo ML, Garcia CM, Larranaga N, Tormo MJ, Gurrea AB, Bingham S, Khaw KT, Allen N, Key T, Trichopoulou A, Vasilopoulou E, Trichopoulos D, Pala V, Palli D, Tumino R, Mattiello A, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Berglund G, Manjer J, Lundin E, Lukanova A, Slimani N, Jenab M, Kaaks R, Riboli E (2007) Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 18(4):399–413. doi:10.1007/s10552-006-0113-8
Lundqvist E, Kaprio J, Verkasalo PK, Pukkala E, Koskenvuo M, Soderberg KC, Feychting M (2007) Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. Int J Cancer 121(4):810–818. doi:10.1002/ijc.22746
McCullough ML, Patel AV, Patel R, Rodriguez C, Feigelson HS, Bandera EV, Gansler T, Thun MJ, Calle EE (2008) Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomark Prev 17(1):73–79. doi:10.1158/1055-9965.epi-07-2567
Song YM, Sung J, Ha M (2008) Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 26(20):3395–3402. doi:10.1200/jco.2007.15.7867
Conroy MB, Sattelmair JR, Cook NR, Manson JE, Buring JE, Lee IM (2009) Physical activity, adiposity, and risk of endometrial cancer. Cancer Causes Control 20(7):1107–1115. doi:10.1007/s10552-009-9313-3
Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2009) The impact of BMI on subgroups of uterine cancer. Br J Cancer 101(3):534–536. doi:10.1038/sj.bjc.6605158
Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, Deapen D, Ursin G, Horn-Ross PL (2010) Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes Control 21(9):1407–1416. doi:10.1007/s10552-010-9568-8
Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW (2010) Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J Cancer 126(2):490–499. doi:10.1002/ijc.24718
Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, Paskett ED (2011) Obesity in relation to endometrial cancer risk and disease characteristics in the Women’s Health Initiative. Gynecol Oncol 121(2):376–382. doi:10.1016/j.ygyno.2011.01.027
Kabat GC, Heo M, Miller AB, Rohan TE (2013) Scaling of weight for height in relation to risk of cancer at different sites in a cohort of Canadian women. Am J Epidemiol 177(1):93–101. doi:10.1093/aje/kws270
Alford SH, Rattan R, Buekers TE, Munkarah AR (2015) Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Cancer 121(3):441–447. doi:10.1002/cncr.28952
Dougan MM, Hankinson SE, Vivo ID, Tworoger SS, Glynn RJ, Michels KB (2015) Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. Int J Cancer 137(3):625–637. doi:10.1002/ijc.29427
Kabat GC, Xue X, Kamensky V, Lane D, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE (2015) Risk of breast, endometrial, colorectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures. Cancer Causes Control 26(2):219–229. doi:10.1007/s10552-014-0501-4
Sponholtz TR, Palmer JR, Rosenberg L, Hatch EE, Adams-Campbell LL, Wise LA (2016) Body size, metabolic factors, and risk of endometrial cancer in black women. Am J Epidemiol 183(4):259–268. doi:10.1093/aje/kwv186
Weiss JM, Saltzman BS, Doherty JA, Voigt LF, Chen C, Beresford SA, Hill DA, Weiss NS (2006) Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Am J Epidemiol 164(1):56–62. doi:10.1093/aje/kwj152
Torres ML, Weaver AL, Kumar S, Uccella S, Famuyide AO, Cliby WA, Dowdy SC, Gostout BS, Mariani A (2012) Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol 120(5):998–1004. doi:10.1097/AOG.0b013e31826b9fef
Friedenreich CM, Biel RK, Lau DC, Csizmadi I, Courneya KS, Magliocco AM, Yasui Y, Cook LS (2011) Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Cancer Epidemiol Biomark Prev 20(11):2384–2395. doi:10.1158/1055-9965.epi-11-0715
Stevens VL, Jacobs EJ, Patel AV, Sun J, Gapstur SM, McCullough ML (2014) Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones. Cancer Causes Control 25(3):321–328. doi:10.1007/s10552-013-0333-7
Stevens VL, Jacobs EJ, Sun J, McCullough ML, Patel AV, Gaudet MM, Teras LR, Gapstur SM (2012) Weight cycling and risk of endometrial cancer. Cancer Epidemiol Biomark Prev 21(5):747–752. doi:10.1158/1055-9965.epi-12-0038
Yang TY, Cairns BJ, Allen N, Sweetland S, Reeves GK, Beral V (2012) Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer 107(1):169–175. doi:10.1038/bjc.2012.229
Carlson MJ, Thiel KW, Yang S, Leslie KK (2012) Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer. Discov Med 14(76):215–222. doi:10.1016/j.biotechadv.2011.08.021.Secreted
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579–591. doi:10.1038/nrc1408
Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev 11:1531–1543
Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W (2000) Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7. doi:10.1677/erc.0.0070227
Karageorgi S, Hankinson SE, Kraft P, De Vivo I (2010) Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses’ Health Study cohort 1976–2004. Int J Cancer 126(1):208–216. doi:10.1002/ijc.24672
Kleinman D, Karas M, Danilenko M, Arbeli A, Roberts CT, LeRoith D, Levy J, Sharoni Y (1996) Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins. Endocrinology 137(3):1089–1095
Yang S, Thiel KW, Leslie KK (2011) Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab 22. doi:10.1016/j.tem.2011.01.005
Austin H, Austin JM Jr, Partridge EE, Hatch KD, Shingleton HM (1991) Endometrial cancer, obesity, and body fat distribution. Cancer Res 51(2):568–572
Benjamin F, Deutsch S (1976) Plasma levels of fractionated estrogens and pituitary hormones in endometrial carcinoma. Am J Obstet Gynecol 126(6):638–647
Nyholm HC, Nielsen AL, Lyndrup J, Dreisler A, Hagen C, Haug E (1993) Plasma oestrogens in postmenopausal women with endometrial cancer. Br J Obstet Gynaecol 100(12):1115–1119
Pettersson B, Bergström R, Johansson EDB (1986) Serum estrogens and androgens in women with endometrial carcinoma. Gynecol Oncol 25 (2):223–233. doi:10.1016/0090-8258(86)90103-4
Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, Koenig KL, Shore RE, Kim MY, Levitz M, Mittal KR, Raju U, Banerjee S, Toniolo P (2001) Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 84(7):975–981. doi:10.1054/bjoc.2001.1704
Arem H (2005) Irwin ML (2013) Obesity and endometrial cancer survival: a systematic review. Int J Obes 37(5):634–639. doi:10.1038/ijo.2012.94
Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A, Campbell WS, Franz C, Kahle L, Taylor PR (1994) The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control 5(1):53–60. doi:10.1007/BF01830726
Danforth KN, Eliassen AH (2010) The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women. … J Cancer 126(1):199–207. doi:10.1002/ijc.24709
Gimes G, Szarvas Z, Siklósi G (1986) Endocrine factors in the etiology of endometrial carcinoma. Neoplasma 33(3):393–397
Mollerstrom G, Carlstrom K, Lagrelius A, Einhorn N (1993) Is there an altered steroid profile in patients with endometrial carcinoma? Cancer 72(1):173–181
Wild S, Pierpoint T, Jacobs H, McKeigue P (2000) Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Cambridge, England) 3(2):101–105
Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, Freedman L, Mashiach S, Lunenfeld B (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147(11 SUPPL.):1038–1042. doi:10.1093/oxfordjournals.aje.a009397
Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, Pagotto U, Pasquali R (2006) Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab 91(10):3970–3980. doi:10.1210/jc.2005-2250
Oppelt PG, Mueller A, Jentsch K, Kronawitter D, Reissmann C, Dittrich R, Beckmann MW, Cupisti S (2010) The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 118(9):633–637. doi:10.1055/s-0029-1237705
Roy RN, Gerulath AH, Cecutti A, Bhavnani BR (1999) Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium. Mol Cell Endocrinol 153(1–2):19–27. doi:10.1016/S0303-7207(99)00092-1
Berstein LM, Kvatchevskaya JO, Poroshina TE, Kovalenko IG, Tsyrlina EV, Zimarina TS, Ourmantcheeva AF, Ashrafian L, Thijssen JHH (2004) Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol 130(11):687–693. doi:10.1007/s00432-004-0587-2
Shaw RJ (2006) Glucose metabolism and cancer. Curr Opin Cell biol 18. doi:10.1016/j.ceb.2006.10.005
Dossus L, Lukanova A, Rinaldi S, Allen N, Cust AE, Becker S, Tjonneland A, Hansen L, Overvad K, Chabbert-Buffet N, Mesrine S, Clavel-Chapelon F, Teucher B, Chang-Claude J, Boeing H, Drogan D, Trichopoulou A, Benetou V, Bamia C, Palli D, Agnoli C, Galasso R, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Onland-Moret NC, Redondo ML, Travier N, Sanchez MJ, Altzibar JM, Chirlaque MD, Barricarte A, Lundin E, Khaw KT, Wareham N, Fedirko V, Romieu I, Romaguera D, Norat T, Riboli E, Kaaks R (2013) Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort—a factor analysis. Am J Epidemiol 177(8):787–799. doi:10.1093/aje/kws309
Randle PJGPBHCNNEA (1963) The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281(7285):785–789. doi:10.1016/S0140-6736(63)91500-9
Ayabe T, Tsutsumi O, Sakai H, Yoshikawa H, Yano T, Kurimoto F, Taketani Y (1997) Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer. Endocr J 44(3):419–424
Friedenreich CM, Langley AR, Speidel TP, Lau DCW, Courneya KS, Csizmadi I, Magliocco AM, Yasui Y, Cook LS (2012) Case-control study of markers of insulin resistance and endometrial cancer risk. Endocr Relat Cancer 19(6):785–792. doi:10.1530/ERC-12-0211
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X, Ho GYF, Einstein MH, Kaplan RC, Burk RD, Wylie-Rosett J, Pollak MN, Anderson G, Howard BV, Strickler HD (2008) A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology) 17(4):921–929. doi:10.1158/1055-9965.EPI-07-2686
Anderson KE, Anderson E, Mink PJ, Ching Ping H, Kushi LH, Sellers TA, Lazovich D, Folsom AR (2001) Diabetes and endometrial cancer in the Iowa Women’s Health Study. Cancer Epidemiol Biomark Prev 10(6):611–616
Friberg E, Orsini N, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50(7):1365–1374. doi:10.1007/s00125-007-0681-5
Lambe M, Wigertz A, Garmo H, Walldius G, Jungner I, Hammar N (2011) Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer. Cancer Causes Control (CCC) 22(8):1163–1171. doi:10.1007/s10552-011-9794-8
Luo J, Beresford S, Chen C, Chlebowski R, Garcia L, Kuller L, Regier M, Wactawski-Wende J, Margolis KL (2014) Association between diabetes, diabetes treatment and risk of developing endometrial cancer. Br J Cancer 111(7):1432–1439. doi:10.1038/bjc.2014.407
Mu N, Zhu Y, Wang Y, Zhang H, Xue F (2012) Insulin resistance: a significant risk factor of endometrial cancer. Gynecol Oncol 125(3):751–757. doi:10.1016/j.ygyno.2012.03.032
Nead KT, Sharp SJ, Thompson DJ, Painter JN, Savage DB, Semple RK, Barker A, Perry JRB, Attia J, Dunning AM, Easton DF, Holliday E, Lotta LA, O’Mara T, McEvoy M, Pharoah PDP, Scott RJ, Spurdle AB, Langenberg C, Wareham NJ, Scott RA (2015) Evidence of a Causal Association between Insulinemia and Endometrial Cancer: a Mendelian randomization analysis. J Natl Cancer Inst 107(9):1–7. doi:10.1093/jnci/djv178
Saltzman BS, Doherty JA, Hill DA, Beresford SA, Voigt LF, Chen C, Weiss NS (2008) Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 167(5):607–614. doi:10.1093/aje/kwm333
Zhang Z-H, Su P-Y, Hao J-H, Sun Y-H (2013) The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies. Int J Gynecol Cancer (Official Journal of the International Gynecological Cancer Society) 23(2):294–303. doi:10.1097/IGC.0b013e31827b8430
Lau DCW, Teoh H (2013) Benefits of modest weight loss on the management of type 2 diabetes mellitus. Can J Diabetes 37. doi:10.1016/j.jcjd.2013.03.023
Lloret-Linares C, Greenfield JR, Czernichow S (2008) Effect of weight-reducing agents on glycaemic parameters and progression to Type 2 diabetes: a review. Diabet Med 25. doi:10.1111/j.1464-5491.2008.02550.x
Tchernof A, Despres JP (2000) Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res 32(11–12):526–536
Goodman-Gruen D, Barrett-Connor E (2000) Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care 23(7):912–918
Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Mesrine S, Joulin V, Linseisen J, Rohrmann S, Pischon T, Boeing H, Trichopoulos D, Trichopoulou A, Benetou V, Palli D, Berrino F, Tumino R, Sacerdote C, Mattiello A, Quiros JR, Mendez MA, Sanchez MJ, Larranaga N, Tormo MJ, Ardanaz E, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Khaw KT, Bingham S, Allen N, Key T, Jenab M, Riboli E (2007) Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 92(1):255–263. doi:10.1210/jc.2006-1371
Pendyala S, Neff LM, Suarez-Farinas M, Holt PR (2011) Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. Am J Clin Nutr 93(2):234–242. doi:10.3945/ajcn.110.002683
Friedenreich CM, Langley AR, Speidel TP, Lau DC, Courneya KS, Csizmadi I, Magliocco AM, Yasui Y, Cook LS (2013) Case-control study of inflammatory markers and the risk of endometrial cancer. Eur J Cancer Prev [The Official Journal of the European Cancer Prevention Organisation (ECP)] 22(4):374–379. doi:10.1097/CEJ.0b013e32835b3813
Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, Stegger J, Overvad K, Chabbert-Buffet N, Jimenez-Corona A, Clavel-Chapelon F, Rohrmann S, Teucher B, Boeing H, Schutze M, Trichopoulou A, Benetou V, Lagiou P, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Redondo ML, Travier N, Sanchez MJ, Altzibar JM, Chirlaque MD, Ardanaz E, Bueno-de-Mesquita HB, van Duijnhoven FJ, Onland-Moret NC, Peeters PH, Hallmans G, Lundin E, Khaw KT, Wareham N, Allen N, Key TJ, Slimani N, Hainaut P, Romaguera D, Norat T, Riboli E, Kaaks R (2010) Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer 17(4):1007–1019. doi:10.1677/erc-10-0053
Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18):2165–2168
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867. doi:10.1038/nature01322
Purohit A, Reed MJ (2002) Regulation of estrogen synthesis in postmenopausal women. Steroids 67(12):979–983
Greenberg AS, McDaniel ML (2002) Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32(Suppl 3):24–34
Boden G (2011) Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18(2):139–143. doi:10.1097/MED.0b013e3283444b09
Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92(3):347–355
Mihu D, Ciortea R, Mihu CM (2013) Abdominal adiposity through adipocyte secretion products, a risk factor for endometrial cancer. Gynecol Endocrinol 29(5):448–451. doi:10.3109/09513590.2012.752452
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86(5):1930–1935. doi:10.1210/jcem.86.5.7463
Lihn AS, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev (An Official Journal of the International Association for the Study of Obesity) 6(1):13–21. doi:10.1111/j.1467-789X.2005.00159.x
Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94(9):1221–1225. doi:10.1038/sj.bjc.6603051
Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H, Zhao L (2009) Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3 K/AKT pathways in human endometrial cancer cells. Cancer Sci 100(3):389–395. doi:10.1111/j.1349-7006.2008.01053.x
Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao AZ (2007) Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer 14(3):713–720. doi:10.1677/erc-07-0065
Ashizawa N, Yahata T, Quan J, Adachi S, Yoshihara K, Tanaka K (2010) Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol 119(1):65–69. doi:10.1016/j.ygyno.2010.07.007
Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M (2008) The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metab, Clin Exp 57(2):268–273. doi:10.1016/j.metabol.2007.09.011
Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN, Cushman M, Strickler HD, Kaplan RC, Wassertheil-Smoller S, Scherer PE, Ho GY (2011) A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomark Prev 20(5):971–977. doi:10.1158/1055-9965.epi-10-1222
Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G, Trichopoulos D (2003) Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88(3):993–997. doi:10.1210/jc.2002-021209
Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I (2008) Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol 136(1):74–77. doi:10.1016/j.ejogrb.2006.08.012
Ohbuchi Y, Suzuki Y, Hatakeyama I, Nakao Y, Fujito A, Iwasaka T, Isaka K (2014) A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer. Int J Clin Oncol 19(4):667–673. doi:10.1007/s10147-013-0603-0
Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH (2006) Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106(11):2376–2381. doi:10.1002/cncr.21866
Luhn P, Dallal CM, Weiss JM, Black A, Huang WY, Lacey JV Jr, Hayes RB, Stanczyk FZ, Wentzensen N, Brinton LA (2013) Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomark Prev 22(7):1304–1312. doi:10.1158/1055-9965.epi-13-0258
Linkov F, Maxwell GL, Felix AS, Lin Y, Lenzner D, Bovbjerg DH, Lokshin A, Hennon M, Jakicic JM, Goodpaster BH, DeLany JP (2012) Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction. Gynecol Oncol 125(1):114–119. doi:10.1016/j.ygyno.2011.12.439
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. doi:10.1161/circulationaha.109.192644
Trabert B, Wentzensen N, Felix AS, Yang HP, Sherman ME, Brinton LA (2015) Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Cancer Epidemiol Biomark Prev 24(1):261–267. doi:10.1158/1055-9965.epi-14-0923
Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C (1999) Hypertension and hormone-related neoplasms in women. Hypertension 34(2):320–325
Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2009) Serum lipids and endometrial cancer risk: results from the HUNT-II study. Int J Cancer 124(12):2938–2941. doi:10.1002/ijc.24285
Swanson CA, Potischman N, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN, Brinton LA (1994) Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiol Biomark Prev 3(7):575–581
Wallace RB, Hoover J, Barrett-Connor E, Rifkind BM, Hunninghake DB, Mackenthun A, Heiss G (1979) Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the Medications Working Group of the Lipid Research Clinics Program. Lancet 2(8134):112–115
Irwin ML, Mayne ST (2008) Impact of nutrition and exercise on cancer survival. Cancer J (Sudbury, Mass) 14(6):435–441. doi:10.1097/PPO.0b013e31818daeee
Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC (2012) Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 126(2):176–179. doi:10.1016/j.ygyno.2012.04.013
Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23):2754–2764. doi:10.1001/jama.2008.824
Hernan MA, Robins JM (2006) Instruments for causal inference: an epidemiologist’s dream? Epidemiology 17(4):360–372. doi:10.1097/01.ede.0000222409.00878.37
Smith GD, Ebrahim S (2004) Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33(1):30–42. doi:10.1093/ije/dyh132
Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chow WH, Rothman N, Chabrier A, Gaborieau V, Timpson N, Hung RJ, Smith GD (2009) Obesity and cancer: mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol 38(4):971–975. doi:10.1093/ije/dyp162
Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Smith GD, Martin RM (2015) The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control 26(11):1603–1616. doi:10.1007/s10552-015-0654-9
Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Locke AE, Kahali B, Justice AE, Pers TH, Gallinger S, Hayes RB, Baron JA, Caan BJ, Ogino S, Berndt SI, Chanock SJ, Casey G, Haile RW, Du M, Harrison TA, Thornquist M, Duggan DJ, Le Marchand L, Lindor NM, Seminara D, Song M, Wu K, Thibodeau SN, Cotterchio M, Win AK, Jenkins MA, Hopper JL, Ulrich CM, Potter JD, Newcomb PA, Hoffmeister M, Brenner H, White E, Hsu L, Campbell PT (2015) Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomark Prev 24(7):1024–1031. doi:10.1158/1055-9965.epi-14-1309
Wang Y, Lobstein T (2006) Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 1(1):11–25
Wang Y, Lim H (2012) The global childhood obesity epidemic and the association between socio-economic status and childhood obesity. Int Rev Psychiatry 24(3):176–188. doi:10.3109/09540261.2012.688195
Renehan AG, Zwahlen M, Egger M (2015) Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 15(8):484–498. doi:10.1038/nrc3967
Amankwah EK, Friedenreich CM, Magliocco AM, Brant R, Courneya KS, Speidel T, Rahman W, Langley AR, Cook LS (2013) Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype. Am J Epidemiol 177(12):1378–1387. doi:10.1093/aje/kws434
Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 19(12):3119–3130. doi:10.1158/1055-9965.epi-10-0832
Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LA, Anderson KE, Bernstein L, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, Patel AV, Prescott J, Rastogi R, Robien K, Rosenberg L, Schairer C, Ou Shu X, van den Brandt PA, Virkus RA, Wentzensen N, Xiang YB, Xu WH, Yang HP, Brinton LA (2013) The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer 108(3):727–734. doi:10.1038/bjc.2013.2
Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L, Parry S, Thibodeau SN, Haile RW, Gallinger S, Le Marchand L, Lindor NM, Newcomb PA, Hopper JL, Jenkins MA (2011) Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol 117(4):899–905. doi:10.1097/AOG.0b013e3182110ea3
Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, Nicholson WK, Park AB, Petruzella S, Rebbeck TR, Setiawan VW, Signorello LB, Simon MS, Weiss NS, Wentzensen N, Yang HP, Zeleniuch-Jacquotte A, Olson SH (2015) Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control 26(2):287–296. doi:10.1007/s10552-014-0510-3
Levi F, La Vecchia C, Negri E, Franceschi S (1993) Selected physical activities and the risk of endometrial cancer. Br J Cancer 67(4):846–851
Carlson MJ, Thiel KW, Yang S, Leslie KK (2012) Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer. Discov Med 14(76):215–222
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Shaw, E., Farris, M., McNeil, J., Friedenreich, C. (2016). Obesity and Endometrial Cancer. In: Pischon, T., Nimptsch, K. (eds) Obesity and Cancer. Recent Results in Cancer Research, vol 208. Springer, Cham. https://doi.org/10.1007/978-3-319-42542-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-42542-9_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42540-5
Online ISBN: 978-3-319-42542-9
eBook Packages: MedicineMedicine (R0)